RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Leng Chee Chang to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications Leng Chee Chang has written about Liver Neoplasms.
Leng Chee Chang
Connection Strength
0.295
Liver Neoplasms
  1. Li XJ, Chang L, Mi Y, Zhang G, Zhu SS, Zhang YX, Wang HY, Lu YS, Ping YX, Zheng PY, Xue X. Integrated-omics analysis defines subtypes of hepatocellular carcinoma based on circadian rhythm. J Integr Med. 2025 Jul; 23(4):445-456.
    View in: PubMed
    Score: 0.193
  2. Chang L, Wang G, Jia T, Zhang L, Li Y, Han Y, Zhang K, Lin G, Zhang R, Li J, Wang L. Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma. Oncotarget. 2016 Apr 26; 7(17):23988-4004.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support